Cutia Therapeutics (HKG:2487) said its chief executive officer Zhang Lele purchased 20,000 shares of the company in the open market on Oct. 15 and Oct. 16, according to a Thursday filing with the Hong Kong Bourse.
The shares were purchased for HK$241,116 at an average price of about HK$12.056 per share. The filing added that the transactions were carried out using Zhang's personal funds.
The company's shares were 5% higher in recent trading.
Price (HKD): $13.02, Change: $+0.64, Percent Change: +5.17%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments